2. UroToday Home
  3. Conference Highlights
  4. SUFU 2020 Winter Meeting

SUFU 2020: Which Urodynamic Parameters can Predict Outcomes of Intravesical Injections of Onabotulinum Toxin A for Overactive Bladder

Scottsdale, Arizona (UroToday.com) This team asks the question of whether pre procedure urodynamics can predict the outcome of patients undergoing Onabotulinum toxin A injection for refractory overactive bladder. A retrospective review was performed on 418 patients with a mean age of 61. 126 were men. The time period was between 2006-2018. Outcomes were measured using a 5 question PGII. 74% of the patients had urodynamics available for review, 214 women and 95 men. 69% of these cases had idiopathic detrusor activity (IDO).

SUFU20_overactive_bladder.png


They were able to correlate successful treatment outcomes with women who were diagnosed with IDO vs men and women without IDO. The only urodynamic parameter that influenced a successful outcome was in women with increased duration of detrusor contractions.

Presented by: Mehwash Nadeem, Clinical fellow in Female, Functional, Restorative Urology and Neuro-Urology, University College London Hospitals NHS Foundation Trust
Co-Authors: Kristina Aleksejeva, Gemma Scrimgeour, Richard Axell, Habiba Yasmin, Daniyal Motan, Stephen Unterberg, Mahreen Pakzad, Rizwan Hamid, Jeremy Ockrim, Tamsin Greenwell
FFR Urology, University College London Hospital

Written by: Lira Chowdhury, DO, Urology Specialist, Urology Partners of North Texas, PLLC, Fort Worth, Texas at the Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction Winter Meeting, SUFU 2020, February 25 - February 29, 2020, Scottsdale, Arizona